| 시신경척수염 환자에서 리툭시맙 반복 투여 후 발생한 지연성 B형 간염의 재활성화 |
|
이혜선, 성의현, 성원재, 김승현 |
|
한양대학교 의과대학 신경과학교실 |
| Delayed Hepatitis B Reactivation after Repeated Rituximab Treatments for Neuromyelitis Optica Spectrum Disorder |
|
Hyesun Lee, Euihyun Sung, Wonjae Sung, Seung Hyun Kim |
|
Department of Neurology, Hanyang University College of Medicine, Seoul, Korea |
|
|
| Abstract |
|
"Rituximab is a chimeric mouse human anti-CD20 monoclonal antibody that can reduce B cell numbers and antibody levels and has been prescribed for refractory neuromyelitis optica spectrum disorder (NMOSD). We report a case of delayed hepatitis B reactivation after repeated rituximab treatments with antibodies against aquaporin-4 in a seropositive NMOSD patient with chronic hepatitis B infection. Journal of Multiple Sclerosis and Neuroimmunology 12(2):35-38, 2021" |
| Key Words:
Neuromyelitis optica, Hepatitis B, Rituximab |
|
PDF Links
Download Citation
